DEA Denies Petition to Reschedule Cannabis from Schedule I
Key Takeaway
The DEA formally denied two petitions to reschedule cannabis out of Schedule I, concluding that cannabis has no currently accepted medical use and high abuse potential. The decision was widely criticized by reformers but kept Section 280E firmly in place for state-legal operators.
What This Means for Cannabis Businesses
Federal policy changes ripple across the entire cannabis industry. Whether it's rescheduling progress, banking legislation, or court rulings, these developments shape the operating environment for businesses in every legal state. Operators should monitor these developments closely and consult with their legal counsel to understand the implications for their specific markets and operations.
Related Guides
Find Help
Related News
Congressman Presses DOJ and DEA on Cannabis Rescheduling Timeline
New Congressional Research Report on Cannabis Rescheduling Published
Congressional Research Service Releases Comprehensive Cannabis Rescheduling Report
Federal Government Warns About Cannabis and Hemp in Drug Tests
This analysis is based on reporting by Federal Register. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.